Detalhe da pesquisa
1.
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice.
Diabetes Obes Metab
; 26(4): 1492-1501, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234208
2.
Biochemical predictors of diabetic foot osteomyelitis: A potential diagnostic role for parathormone.
Diabetes Metab Res Rev
; 39(1): e3590, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400428
3.
Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.
Int J Mol Sci
; 24(11)2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298586
4.
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs.
Cardiovasc Diabetol
; 21(1): 42, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296336
5.
Neutropenia in patients with hyperthyroidism: Systematic review and meta-analysis.
Clin Endocrinol (Oxf)
; 94(3): 473-483, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799342
6.
The residual cardiorenal risk in type 2 diabetes.
Cardiovasc Diabetol
; 20(1): 36, 2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33546683
7.
Up and down waves of glycemic control and lower-extremity amputation in diabetes.
Cardiovasc Diabetol
; 20(1): 135, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34229673
8.
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression.
Cardiovasc Diabetol
; 20(1): 210, 2021 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663316
9.
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs.
Cardiovasc Diabetol
; 20(1): 236, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915880
10.
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs.
Cardiovasc Diabetol
; 20(1): 189, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526024
11.
Female Sexual Function in Young Women With Type 1 Diabetes and Additional Autoimmune Diseases.
J Sex Med
; 18(1): 219-223, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33223430
12.
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis.
Diabetes Obes Metab
; 23(7): 1672-1676, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33710721
13.
Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
J Med Internet Res
; 23(4): e24552, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769945
14.
Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis.
Stroke
; 51(2): 666-669, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813360
15.
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.
Cardiovasc Diabetol
; 19(1): 115, 2020 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698837
16.
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney.
Cardiovasc Diabetol
; 19(1): 35, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192503
17.
Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta-analysis with meta-regression.
Diabetes Obes Metab
; 22(8): 1397-1405, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250550
18.
Impact of Pituitary Autoimmunity and Genetic Disorders on Growth Hormone Deficiency in Children and Adults.
Int J Mol Sci
; 21(4)2020 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32092880
19.
GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials.
Diabetes Obes Metab
; 21(11): 2576-2580, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373167
20.
Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials.
Diabetes Obes Metab
; 21(8): 1790-1800, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969018